1. Home
  2. NVNO vs STLNW Comparison

NVNO vs STLNW Comparison

Compare NVNO & STLNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

N/A

Current Price

$11.12

Market Cap

6.8M

Sector

Health Care

ML Signal

N/A

STLNW

Starling Oncology Inc. Warrant

N/A

Current Price

$0.04

Market Cap

5.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NVNO
STLNW
Founded
1987
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8M
5.7M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
NVNO
STLNW
Price
$11.12
$0.04
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
15.3K
1.8K
Earning Date
05-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
23.94
EPS
N/A
N/A
Revenue
$31,243.00
$502,729,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$140.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
27.79
52 Week Low
$0.30
$0.04
52 Week High
$13.44
$0.07

Technical Indicators

Market Signals
Indicator
NVNO
STLNW
Relative Strength Index (RSI) 53.08 49.14
Support Level $9.96 $0.05
Resistance Level $11.40 $0.06
Average True Range (ATR) 0.73 0.01
MACD 0.03 -0.00
Stochastic Oscillator 62.91 48.97

Price Performance

Historical Comparison
NVNO
STLNW

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: